Volume 67 Received 13 March 2011 | ||||||||||
| ||||||||||
aDepartment of Chemistry, School of Pharmacy, Fourth Military Medical University, Changle West Road 17, 710032 Xi-An, People's Republic of China, and bDepartment of Pharmacy, Lanzhou General Hospital, Lanzhou Command, Lanzhou 730050, People's Republic of China
Correspondence e-mail: xiaoli_sun@yahoo.cn
In the title compound, C21H28Cl2N3O6, the nitronyl nitroxide ring displays a half-chair conformation, whereas the pyrrolidine ring has an envelope conformation. These two rings are twisted to each other with N-C-C-N torsion angles around the connecting C-C bond of 48.9 (6) and -127.0 (5)°. The benzene ring is nearly perpendicular to the pyrrolidine ring, with torsion angles around the connecting C-C bond of 86.3 (6) and -97.7 (6)°. The crystal structure is stabilized by C-H
O and C-H
hydrogen bonds, which build up a three-dimensional network.
For the chemical and physical properties of nitronyl nitroxides, see: Minguet et al. (2001
); Osiecki & Ullman (1968
); Shemsi et al. (2007
); Wu et al. (2006
). For related structures, see: Shimono et al. (2004
); Minguet et al. (2001
); Tian et al. (2011
). For puckering parameters, see Cremer & Pople (1975
). For a description of the Cambridge Structural Database, see: Allen (2002
).
|
|
|
Data collection: APEX2 (Bruker, 2007
); cell refinement: SAINT (Bruker, 2007
); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEPIII (Burnett & Johnson, 1996
) and ORTEP-3 for Windows (Farrugia, 1997
); software used to prepare material for publication: SHELXTL (Sheldrick, 2008
) and PLATON (Spek, 2009
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: DN2666 ).
We thank the Natural Science Foundation of China (grant Nos. 81001398, 30901883, 20802091, 20802092) for financial support.
Allen, F. H. (2002). Acta Cryst. B58, 380-388.
![[details]](../../../../../../b/graphics/details.gif)
Bruker (2007). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Burnett, M. N. & Johnson, C. K. (1996). ORTEPIII. Report ORNL-6895. Oak Ridge National Laboratory, Tennessee, USA.
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.
![[ISI]](../../../../../../logos/isiborder.gif)
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
![[details]](../../../../../../j/graphics/details.gif)
Flack, H. D. (1983). Acta Cryst. A39, 876-881.
![[details]](../../../../../../a/graphics/details.gif)
Minguet, M., Amabilino, D. B., Wurst, K. & Veciana, J. (2001). J. Solid State Chem. 159, 440-450. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Osiecki, J. H. & Ullman, E. F. (1968). J. Am. Chem. Soc. 90, 1078-1079.
![[ISI]](../../../../../../logos/isiborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Shemsi, A. M., El Ali, B., Ziq, K. A., Morsy, M., Keene, T. D., Decurtins, S. & Fettouhi, M. (2007). Inorg. Chem. Commun. 10, 1355-1359. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Shimono, S., Tamura, R., Ikuma, N., Takimoto, T., Kawame, N., Tamada, O., Sakai, N., Matsuura, H. & Yamauchi, J. (2004). J. Org. Chem. 69, 475-481.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)
Tian, M., Xiang, Z., Zhou, S.-Y., Jing, L.-L., Wang, H.-B. & Sun, X.-L. (2011). Acta Cryst. E67, o425.
![[details]](../../../../../../e/graphics/details.gif)
Wu, Y. H., Bi, L. R., Bi, W., Li, Z., Zhao, M., Wang, C., Ju, J. F. & Peng, S. Q. (2006). Bioorg. Med. Chem. 14, 5711-5720.
![[ChemPort]](../../../../../../logos/chemportborder.gif)